World-renowned physician, Dr. Michael Roizen, MD, continues to update your understanding of the meaning of health by providing an in-depth review of the most impactful health headlines.
Joined by his co-host, Joe Galuski, they discuss the health news that matters most to you.
The duo is later joined by Dr. David B. Agus, author of the New York Times bestsellers, A Short Guide to a Long Life and The End of Illness. Dr. Agus gives an insider's view of what it really means to be "healthy" and how to achieve it.
Bonus!
RealAge Tip
New Device Zaps Migraine Pain
Hour 1: YOU The Owner's Manual Radio 2.1.14
Featuring:
He explains, “Sometimes you have to go to war to understand peace. My work on the front lines of the cancer war has taught me a lot about all things health-related, much of which is surprising and goes against conventional wisdom.” His first book, the #1 New York Times and international bestseller, The End of Illness, reflected this new and different perspective, giving an insider’s view of what it really means to be “healthy” and how to achieve it.
Dr. Agus is professor of medicine and engineering at the Keck School of Medicine of the University of Southern California and the USC Viterbi School of Engineering and heads USC’s Norris Westside Cancer Center and the Center for Applied Molecular Medicine. He is dedicated to finding novel approaches for personalized healthcare. He is also a CBS News contributor, regularly commenting on important health topics. Dr. Agus specializes in treating patients with advanced cancer. His clinical responsibilities include the development of clinical trials for new drugs and treatments for cancer, supported by the National Cancer Institute and other private foundations. He serves leadership roles at the World Economic Forum, among other prestigious organizations. After earning his BA from Princeton University and medical degree from the University of Pennsylvania School of Medicine, he completed his medicinal residency training at Johns Hopkins Hospital, a research fellowship at the National Institutes of Health, and an oncology fellowship at the Memorial Sloan-Kettering Cancer Center.
David B. Agus, MD
Dr. David B. Agus is one of the world’s leading cancer doctors and pioneering biomedical researchers. Over the past 20 years he’s received acclaim for his innovations in medicine and contributions to new technologies that will change how all of us maintain optimal health. He’s also built a reputation for having a unique way of looking at the relationship of the human body to health and disease.He explains, “Sometimes you have to go to war to understand peace. My work on the front lines of the cancer war has taught me a lot about all things health-related, much of which is surprising and goes against conventional wisdom.” His first book, the #1 New York Times and international bestseller, The End of Illness, reflected this new and different perspective, giving an insider’s view of what it really means to be “healthy” and how to achieve it.
Dr. Agus is professor of medicine and engineering at the Keck School of Medicine of the University of Southern California and the USC Viterbi School of Engineering and heads USC’s Norris Westside Cancer Center and the Center for Applied Molecular Medicine. He is dedicated to finding novel approaches for personalized healthcare. He is also a CBS News contributor, regularly commenting on important health topics. Dr. Agus specializes in treating patients with advanced cancer. His clinical responsibilities include the development of clinical trials for new drugs and treatments for cancer, supported by the National Cancer Institute and other private foundations. He serves leadership roles at the World Economic Forum, among other prestigious organizations. After earning his BA from Princeton University and medical degree from the University of Pennsylvania School of Medicine, he completed his medicinal residency training at Johns Hopkins Hospital, a research fellowship at the National Institutes of Health, and an oncology fellowship at the Memorial Sloan-Kettering Cancer Center.